Ultragenyx Pharmaceutical(RARE) - 2022 Q2 - Earnings Call Transcript
Ultragenyx Pharmaceutical(RARE)2022-07-29 12:00
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Q2 2022 Earnings Conference Call July 28, 2022 5:00 PM ET Company Participants Joshua Higa - Executive Director & Head, Investor Relations Emil Kakkis - Chief Executive Officer & President Erik Harris - Chief Commercial Officer Mardi Dier - Chief Financial Officer Camille Bedrosian - Chief Medical Officer Conference Call Participants Gena Wang - Barclays Joel Beatty - Baird Dae Gon Ha - Stifel Tazeen Ahmad - Bank of America Cory Kasimov - JPMorgan Yaron Werber - ...